Literature DB >> 1556145

Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution.

K Hanasaki1, H Arita.   

Abstract

We showed in an earlier study (Arita, H., Hanasaki, K., Nakano, T., Oka, S., Teraoka, H., and Matsumoto, K. (1991) J. Biol. Chem. 266, 19139-19141) that there is a high affinity and specific binding site for mammalian group I phospholipase A2 (PLA2-I) in Swiss 3T3 fibroblast cells. Analysis of the cellular distribution in rat using 125I-PLA2-I as a radioligand indicated the presence of this site in various cells, including vascular smooth muscle cells (VSMC), vascular endothelial cells, synovial cells, chondrocytes, and gastric mucosal cells. Scatchard analysis of rat VSMC revealed the existence of a single class of binding site with a Kd value of 1.60 nM and a Bmax value of 51.0 fmol/10(6) cells. The mammalian mature type of PLA2s-I derived from several animal species specifically recognized the same site in cells and stimulated DNA synthesis, whereas its inactive zymogen, mammalian group II PLA2s, and snake and bee venom PLA2s showed much lesser activities. 125I-PLA2-I bound to VSMC was rapidly internalized and subsequently released from the cells as trichloroacetic acid-soluble radioactivity. Down-regulation of the PLA2-I site was observed in the treatment of VSMC with cAMP-elevating agents, as well as glucocorticoids. Affinity labeling experiments indicated that PLA2-I binds to a single polypeptide with a mass of approximately 200,000 daltons. These results suggest a novel PLA2-I action on the cellular function via its specific binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Expression and induction of secretory phospholipase A2 group IB in brain.

Authors:  Miriam Kolko; Nanna R Christoffersen; Hélène Varoqui; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-11       Impact factor: 5.046

2.  Binding and internalization of extracellular type-I phospholipase A2 in uterine stromal cells.

Authors:  G P Rossini; J M Fayard; C Tessier; C Laugier
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

Review 3.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

4.  Proliferative effect of ammodytin L from the venom of Vipera ammodytes on 208F rat fibroblasts in culture.

Authors:  S Rufini; M P Cesaroni; N Balestro; P Luly
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 5.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

Review 6.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

7.  A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury.

Authors:  Elizabeth J Dial; Duy M Tran; Jimmy J Romero; Mayssa Zayat; Lenard M Lichtenberger
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

8.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

9.  The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Authors:  Y Weinrauch; P Elsbach; L M Madsen; A Foreman; J Weiss
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

10.  Specific interaction of pancreatic elastase and leucocytes to produce oxygen radicals and its implication in pancreatitis.

Authors:  N Tsuji; N Watanabe; T Okamoto; Y Niitsu
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.